Stay updated on Venetoclax Combo vs Azacitidine in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax Combo vs Azacitidine in AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new PubMed citation by Venditti et al. was added to the Publications From PubMed section. The prior 'Online ahead of print' listing for the same article was removed.
    Difference
    0.0%
    Check dated 2025-12-10T19:08:55.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a note that PubMed-derived publications are automatically populated and may not relate to the study, and updated the revision tag to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-26T13:51:44.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The government funding status notice at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-19T08:30:48.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The screenshots show only minor formatting changes with no alteration to core study details such as the title, NCT number, sponsor, enrollment, locations, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-28T05:11:35.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Core content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.
    Difference
    1%
    Check dated 2025-10-06T15:54:04.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.
    Difference
    0.2%
    Check dated 2025-09-29T09:51:38.000Z thumbnail image

Stay in the know with updates to Venetoclax Combo vs Azacitidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.